The biopharmaceutical industry’s commercial model has been an important part of each company’s success, but the current capabilities and strategies are unlikely to suffice for future …

May 6, 2021 · Consumers may appreciate pharma companies’ efforts to speed up the process of bringing COVID-19 vaccines to market. How might biopharma continue to innovate while …

Artificial intelligence-enabled technologies are transforming the different parts of the biopharma industry value chain, creating new business opportunities. Explore Deloitte's collection of …

Inorganic growth activity in life sciences— have we reached the bottom? Our previous report outlined a steep decline in life sciences deal-making in the first half of 2022 from record levels …

Discover industry insights and audit, tax, and consulting services that drive impact from Deloitte’s global network of member firms.

Apr 10, 2024 · バイオ・創薬スタートアップは新規モダリティの創出の原動力であり、ひとたび新規モダリティが上市されると、それらは大きな市場を形成し、同時に業界構造についても …

2024年10月から11月にかけて実施された2025年度版グローバル自動車消費者調査では、次の4つの主要なトレンド取り上げる。 ほとんどの市場でバッテリー式電気自動車（BEV）への関 …

Deloitte US | Audit, Consulting, Advisory, and Tax Services

Jul 19, 2024 · In 2024, many biopharma companies are looking for novel ways to marry the rich data sets of science with the latest GenAI technologies.15 Alternatively, technology giants with …

More than 3/4 of biopharma companies agree that their organizations need new leaders to succeed in the digital age. Many companies are recruiting outside of life sciences for digital …